{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:39:07Z","timestamp":1792636747777,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05225-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:44:44Z","timestamp":1784904284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rituximab and corticosteroids for M-protein-negative PGNMID: case report"],"prefix":"10.1186","volume":"27","author":[{"given":"Zhuolin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuopeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"12","key":"5225_CR1","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11255-017-1594-y","volume":"49","author":"M Ciocchini","year":"2017","unstructured":"Ciocchini M, Arbelbide J, Musso CG. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity. Int Urol Nephrol. 2017;49(12):2171\u20135.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"5225_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.kint.2025.04.007","volume":"108","author":"SH Nasr","year":"2025","unstructured":"Nasr SH, Royal V, Best Rocha A, Buttner-Herold M, Roufosse C, Bridoux F, et al. Renal Pathology Society\/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions. Kidney Int. 2025;108(2):184\u201393.","journal-title":"Kidney Int"},{"issue":"9","key":"5225_CR3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1681\/ASN.2009010110","volume":"20","author":"SH Nasr","year":"2009","unstructured":"Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, et al. Proliferative Glomerulonephritis with Monoclonal IgG Deposits. J Am Soc Nephrol. 2009;20(9):2055\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5225_CR4","first-page":"98","volume":"14","author":"T Reiter","year":"2021","unstructured":"Reiter T, Nackenhorst M. Monoclonal gammopathy of renal significance. memo - Magazine Eur Med Oncol. 2021;14(1):98\u2013102.","journal-title":"memo - Magazine Eur Med Oncol"},{"issue":"22","key":"5225_CR5","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292\u20135.","journal-title":"Blood"},{"issue":"1","key":"5225_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45\u201359.","journal-title":"Nat Rev Nephrol"},{"key":"5225_CR7","doi-asserted-by":"publisher","first-page":"1637435","DOI":"10.3389\/fmed.2025.1637435","volume":"12","author":"Q Ji","year":"2025","unstructured":"Ji Q, Yu S, Zhou X, Wang Z, Guo X, Zhong Y. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID): three Case Reports and systematic review. Front Med (Lausanne). 2025;12:1637435.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"5225_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","volume":"94","author":"R Gumber","year":"2018","unstructured":"Gumber R, Cohen JB, Palmer MB, Kobrin SM, Vogl DT, Wasserstein AG, et al. A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int. 2018;94(1):199\u2013205.","journal-title":"Kidney Int"},{"issue":"6","key":"5225_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1053\/j.ajkd.2019.04.029","volume":"74","author":"JJ Hogan","year":"2019","unstructured":"Hogan JJ, Alexander MP, Leung N. Dysproteinemia and the Kidney: Core Curriculum 2019. Am J Kidney Dis. 2019;74(6):822\u201336.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5225_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfz176","volume":"36","author":"F Bridoux","year":"2021","unstructured":"Bridoux F, Javaugue V, Nasr SH, Leung N. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective. Nephrol Dial Transpl. 2021;36(2):208\u201315.","journal-title":"Nephrol Dial Transpl"},{"key":"5225_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2369-9-11","volume":"9","author":"CA Hutchison","year":"2008","unstructured":"Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol. 2008;9:11.","journal-title":"BMC Nephrol"},{"key":"5225_CR13","doi-asserted-by":"crossref","unstructured":"Santana de Roberts R, Batal I, Aljareh A, Jim B. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits associated with parvovirus B19. BMJ Case Rep. 2021;14(6).","DOI":"10.1136\/bcr-2021-243061"},{"issue":"7","key":"5225_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ajh.26155","volume":"96","author":"JJ Castillo","year":"2021","unstructured":"Castillo JJ, Callander NS, Baljevic M, Sborov DW, Kumar S. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. Am J Hematol. 2021;96(7):846\u201353.","journal-title":"Am J Hematol"},{"issue":"3","key":"5225_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.revmed.2017.03.012","volume":"39","author":"V Javaugue","year":"2018","unstructured":"Javaugue V, Bouteau I, Sirac C, Quellard N, Diolez J, Colombo A, et al. [Classification and therapeutic management of monoclonal gammopathies of renal significance]. Rev Med Interne. 2018;39(3):161\u201370.","journal-title":"Rev Med Interne"},{"issue":"22","key":"5225_CR16","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","volume":"122","author":"JP Fermand","year":"2013","unstructured":"Fermand JP, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA, et al. How I treat monoclonal gammopathy of renal significance (MGRS). Blood. 2013;122(22):3583\u201390.","journal-title":"Blood"},{"issue":"5","key":"5225_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978;64(5):814\u201326.","journal-title":"Am J Med"},{"issue":"3","key":"5225_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40620-020-00723-2","volume":"33","author":"RCM van Kruijsdijk","year":"2020","unstructured":"van Kruijsdijk RCM, Abrahams AC, Nguyen TQ, Minnema MC, Jacobs JFM, Limper M. Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? Two case reports and literature review. J Nephrol. 2020;33(3):611\u20137.","journal-title":"J Nephrol"},{"issue":"4S","key":"5225_CR19","first-page":"S1","volume":"100","author":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","year":"2021","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1\u2013276.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05225-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:06:11Z","timestamp":1792634771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05225-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5225"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05225-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the hospital ethics committee (ky112025173). The patient was fully informed of the case report purpose, publication process, and privacy protections, and provided written informed consent for the use of anonymized clinical, pathological, and radiological data. All personally identifiable information has been redacted.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I consent to publication. I presented with gross hematuria, edema, and rapidly worsening kidney function, complicated by a severe infection. After two hospitalizations and long-term follow-up, my hematuria resolved and kidney function recovered to near-normal. I hope my case can aid medical research.","order":3,"name":"Ethics","label":"Patient perspective","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"623"}}